Vanessa Ragaglia
Corporate Officer/Principal bei Garnet BioTherapeutics, Inc.
Profil
Vanessa Ragaglia is currently working as the Lab Director at Celebration Stem Cell Centre and as the Vice President-Research at Garnet BioTherapeutics, Inc. She completed her undergraduate degree at Trinity College (Connecticut) and her doctorate degree at The Ohio State University College of Medicine.
Aktive Positionen von Vanessa Ragaglia
| Unternehmen | Position | Beginn |
|---|---|---|
Garnet BioTherapeutics, Inc.
 Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 01.01.2000 |
| Celebration Stem Cell Centre | Corporate Officer/Principal | - |
Ausbildung von Vanessa Ragaglia
| The Ohio State University College of Medicine | Doctorate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Garnet BioTherapeutics, Inc.
Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Commercial Services |
| Celebration Stem Cell Centre |
